陈峰 研究员
硕士招生类型：学术型
硕士招生专业：生物医学工程
博士招生类型：学术型
博士招生专业：基础医学（生物医学工程方向）
所在院系：附属第十人民医院
联系方式：fchen@tongji.edu.cn
课题组链接：
研究方向
主要任职
科研业绩

仿生材料与再生医学
担任同济大学附属第十人民医院骨科实验室PI（主持工作）,同济大学转化医学高等研究院研究员，十院攀登人才计划领军人才（2018）。担任国家自然科学基金函评专家、浙江省/上海市项目评审专家；曾担任Current Tissue Engineering编委、International Journal of Polymer Science客座编辑；是中国生物材料学会会员、中美华人纳米医学及纳米生物技术学会终身会员、中国抗癌协会纳米肿瘤学专业委员会专业会员；担任Biomaterials、Chemistry of Materials、ACS Applied materials & interfaces、Applied Materials Today等三十余种学术期刊审稿人。
Prof. Feng Chen is a PI and co-leader of Orthopaedic Laboratory in Tenth People's Hospital affiliated to Tongji University, and has been selected into the Climbing Talents Program (First class, 2018) of leading talents of Tenth People's Hospital. He is a member of evaluation experts for the projects of National Natural Science Foundation of China, Zhejiang and Shanghai governments. He served as a member of the editorial board of Current Tissue Engineering and a guest editor of the International Journal of Polymer Science. He is a member of the several academic societies, such as Chinese Biomaterials Society and Chinese-American Society of Nanomedicine and Nanobiotechnology. He has served as a reviewer of more than 30 academic journals including Biomaterials, Chemistry of Materials, ACS Applied materials & interfaces, and Applied Materials Today.
自08年起，在仿生材料和生物医学研究领域发表和被接收SCI论文100余篇，其中第一/通讯作者论文40余篇，包括ACS Nano、Materials Horizons、Small、Biomaterials、ACS Applied materials & interfaces、Acta Biomaterialia等国际重要学术期刊，论文被引4100余次，H指数35。在仿生磷酸钙生物材料及其再生医学、药物递送等领域的应用研究方面开展了系统的工作，发表的纳米磷酸钙及生物医学应用相关研究论文数量在全球作者中排名前10。获中国发明专利授权18项，美国专利授权1项。主持科研项目10余项，其中国家、省部级项目7项，总科研经费超1000万元。研究成果曾得到了人民日报、中国科学报及英国皇家物理学会等国内外媒体的广泛关注。
代表性论文：
1.Cao WT, Feng W, Jiang YY, Ma Chang, Zhou ZF, Ma MG,* Chen Y,* Chen F.* Two-dimensional MXene-reinforced robust surface superhydrophobicity with self-cleaning and photothermal-actuating binary effects, Materials Horizons, 2019, 6, 1057 (IF: 14.356)
2.Chen F, Zhu YJ.* Large-Scale Automated Production of Highly Ordered Ultralong Hydroxyapatite Nanowires and Construction of Various Fire-Resistant Flexible Ordered Architectures, ACS Nano, 2016; 10 (12): 11483–11495 (IF: 13.903)
3.Cao WT, Chen FF, Zhu YJ*, Zhang YG, Jiang YY, Ma MG*, Chen F * Binary Strengthening and Toughening of MXene/Cellulose Nanofiber Composite Paper with Nacre-Inspired Structure and Superior Electromagnetic Interference Shielding Properties, ACS Nano, 2018, 12 (5), 4583–4593 (IF: 13.903)
4.Jiang YY, Zhou ZF, Zhu YJ,* Chen FF, Lu BQ, Cao WT, Zhang YG, Cai ZD,* Chen, F.* Enzymatic Reaction Generates Biomimic Nanominerals with Superior Bioactivity. Small, 2018，14：** (IF: 10.856).
5.Zhou ZF, Sun TW, Chen F,* Zuo DQ, Wang HS, Hua YQ, Cai ZD, * and Tan J*, Calcium phosphate-phosphorylated adenosine hybrid microspheres for anti-osteosarcoma drug delivery and osteogenic differentiation, Biomaterials, 2017; 121: 1–14 (IF: 10.273)
6.Chen F, Huang P, Zhu YJ*, Wu J, Cui DX.* Multifunctional Eu3+/Gd3+ dual-doped calcium phosphate vesicle-like nanospheres for sustained drug release and imaging. Biomaterials, 2012; 33: 6447-55. (IF: 10.273)
7.Chen F, Huang P, Zhu YJ*, Wu J, Zhang CL, Cui DX*. The photoluminescence, drug delivery and imaging properties of multifunctional Eu3+/Gd3+ dual-doped hydroxyapatite nanorods. Biomaterials, 2011; 32: 9031-9. (IF: 10.273)
8.Zhang YG, Zhu YJ*, Xiong ZC, Wu J, Chen F*, Bioinspired Ultralight Inorganic Aerogel for Highly Efficient Air Filtration and Oil–Water Separation, ACS Applied Materials and Interfaces, 18, 10, 13019–13027. (IF: 8.456)
9.Zhang YG, Zhu YJ*, Chen F*, Sun TW. Biocompatible, ultralight, strong hydroxyapatite networks based on hydroxyapatite microtubes with excellent permeability and ultralow thermal conductivity. ACS Applied Materials and Interfaces, 2017; 9: 7918-28. (IF: 8.456)
10.Sun TW, Yu WL, Zhu YJ*, Yang RL, Shen YQ, Chen DY, He* YH, Chen F*. Hydroxyapatite Nanowire@Magnesium Silicate Core-Shell Hierarchical Nanocomposite: Synthesis and Application in Bone Regeneration. ACS Applied Materials and Interfaces, 2017, 9, 16435-16447. (IF: 8.456)
在研项目：
1. 宁波市“科技创新2025”生物医药与高端医疗器械科技创新重大专项，2018B10040，新型抗菌和骨诱导型硬组织修复替代材料与器械产业化，2018.7.1-2022.12.31，2500万元（宁波市500万元，企业2000万元），在研，主持
2. 国家自然科学基金面上项目，**，仿生制备活性矿物载体用于骨肉瘤术后免疫治疗和缺损修复，2018.01-2021.12，62万元，在研，主持
3. 上海市自然科学基金探索类项目，18ZR**，仿线粒体的微环境制备活性生物矿物，2018.6 -2021.5，20万元，在研，主持
4.同济大学附属第十人民医院攀登计划领军人才项目，2018SYPDRC001，人才项目专项经费，2018.9-2021.9，100万元，在研，主持
5. 同济大学附属第十人民医院PI启动经费，，2018.3-2021.3，100万元，在研，主持
6. 国家重点研发计划（青年），2016YFA**，新型有机/无机杂化纳米靶向药物，2016-2020，主持经费94.2万（总经费471万元），研究骨干
Prof. Feng Chen has published more than 100 papers in the field of biomimetic materials and biomedical research, including ACS Nano, Materials Horizons, Small, Biomaterials, ACS Applied materials & interfaces. These papers have been cited more than 4,100 times with an H-index of 35. He has carried out systematic work in the biomimetic biomaterials and their applications in regenerative medicine. He has obtained 18 Chinese invention patents and one US patent. He has led more than 10 projects with a total research funding of over 10 million Yuan. His research results have been widely concerned by the People